Akeso

冠科美博

Akeso

Biotech/Healthcare

Guanke Meibo Co., Ltd., founded in 2021 and located in the Hong Kong Special Administrative Region, is an innovative oncology drug developer. It mainly develops novel humanized monoclonal antibodies that restore the body's immune system's ability to recognize and kill cancer cells, as well as…

Latest round: IPO (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-03-01